GelTex Pharmaceuticals Incorporated

GelTex Pharmaceuticals, Inc. is developing non-absorbed, polymer-based pharmaceuticals that selectively bind to andeliminate target substances from the intestinal tract. In October 1998, the Company received approval from the United States Food and Drug Administration (the "FDA") for its lead product Renagel(R)* Capsules (sevelamer hydrochloride).

Additionally, throughout 1998, the Company continued its product development efforts focused on therapeutic agents for the treatment of hypercholesterolemia (elevated LDL cholesterol levels); obesity; and infectious diseases.

Contact Details: 9 Fourth Avenue Waltham MA 02451 United States of America Tel: 781 290 5888 Fax: 617 290 5890 Email: WWW: www.geltex.com/

Loading...

Recent Publications by GelTex Pharmaceuticals Incorporated:
Bile acid binding to sevelamer HCl. BACKGROUND: Clinical studies have shown sevelamer HCl (Renagel) to be...	14th January, 2003	GelTex Pharmaceuticals, Waltham, Massachusetts, USA.	Kidney Int. 2002 Aug;62(2):611-9. DOI Direct Link
A phosphate binding assay for sevelamer hydrochloride by ion chromatography. Sevelamer hydrochloride is a cross-linked polymeric amine; it is the...	25th March, 2000	GelTex Pharmaceuticals, Waltham, MA 02154, USA. www.geltex.com.	J Pharm Biomed Anal. 1999 May;19(6):911-5.

BioNews Results for GelTex Pharmaceuticals Incorporated:
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer	FinanzNachrichten.de:  Nov 16 2009 12:34AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Washington Business Journal:  Nov 16 2009 1:25AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	St Louis Business Journal:  Nov 16 2009 12:45AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	San Jose Business Journal:  Nov 16 2009 12:35AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Reuters:  Nov 16 2009 12:43AM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more GelTex Pharmaceuticals Incorporated news.

GelTex Pharmaceuticals Incorporated Patents:
US Patent No.	Title
5917007	Process for removing bile salts from a patient and alkylated compositions therefor
6083497	Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
6129910	Water-insoluble noncrosslinked bile acid sequestrants
6177478	Method for reducing oxalate
6187762	Polyvalent polymers for the treatment of rotavirus infection
→View more GelTex Pharmaceuticals Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 620 times since April 2007, the link to the organisation's website has been followed 121 times

Recent Search Terms used to find this page: geltex | GelTex website | geltex pharmaceuticals | geltex pharmaceuticals | geltex pharmaceuticals | geltex | GelTex Pharmaceuticals Incorporated | Geltex Pharmaceuticals Waltham ma | Geltex Pharmaceuticals Waltham ma | geltex | .

Search for more companies in Waltham

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for GelTex Pharmaceuticals Incorporated